Solventum Corporation SOLV
NYSE · United States · Health Services
$88.15-1.17 (-1.31%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | 2.55 | 1.90 | +33.9% | $2.21B | +2.6% | -5.7%$87.94→$82.96 |
| Q1 2026 | 2026-05-05 | 1.48 | 1.35 | +9.6% | — | — | +5.3%$67.44→$70.99 |
| Q4 2025 | 2026-02-26 | 1.57 | 1.50 | +4.7% | — | — | -1.2%$75.08→$74.20 |
| Q3 2025 | 2025-11-06 | 1.50 | 1.43 | +4.9% | — | — | +5.7%$67.69→$71.52 |
| Q4 2024 | 2025-02-27 | 1.41 | 1.31 | +7.6% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.